Nachum Kaplan
Corporate Officer/Principal en Tel-Aviv University .
Cargos activos de Nachum Kaplan
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Tel-Aviv University
Tel-Aviv University Other Consumer ServicesConsumer Services Tel-Aviv University operates as a university in Israel. Its faculties include arts, engineering, science, humanities, law, life science, management, medicine, and social science. The company was founded in 1956 and is headquartered in Ramat Aviv, Israel. | Corporate Officer/Principal | 21/04/2010 | - |
Historial de carrera de Nachum Kaplan
Antiguos cargos conocidos de Nachum Kaplan.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Affinium Pharmaceuticals Ltd.
Affinium Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Affinium Pharmaceuticals Ltd. is a holding company, which engages in the provision of clinical development of antibacterial. It specializes in hte development of antibiotics that targets the bacterial fatty acid synthesis pathway. It focuses on small molecule antibacterials targeting FabI, an essential enzyme in the bacterial fatty acid cycle. The company was founded in 2000 and is headquartered in Austin, TX. | Director Técnico/Científico/I+D | 01/10/2013 | - |
Corporate Officer/Principal | 21/04/2010 | 01/10/2013 |
Formación de Nachum Kaplan.
Tel-Aviv University | Doctorate Degree |
Estadísticas
Internacional
Estados Unidos | 2 |
Israel | 2 |
Operativa
Corporate Officer/Principal | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Doctorate Degree | 1 |
Sectorial
Health Technology | 2 |
Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 1 |
---|---|
Affinium Pharmaceuticals Ltd.
Affinium Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Affinium Pharmaceuticals Ltd. is a holding company, which engages in the provision of clinical development of antibacterial. It specializes in hte development of antibiotics that targets the bacterial fatty acid synthesis pathway. It focuses on small molecule antibacterials targeting FabI, an essential enzyme in the bacterial fatty acid cycle. The company was founded in 2000 and is headquartered in Austin, TX. | Health Technology |
- Bolsa de valores
- Insiders
- Nachum Kaplan
- Experiencia